SIAIS-178

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameSIAIS-178
Drug Alias NameSIAIS-178
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProteolysisBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsLeukemia, Myeloid, Chronic-Phase
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghaiTech University
China Registration ClassN/A

Develop Information

Active CompaniesShanghaiTech University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Chronic-Phase
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A